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Introduction
Several surgical procedures are performed under
regional anaesthesia. Intraoperative comfort and patient
satisfaction during these surgical procedures can be improved
with the use of supplemental intravenous sedation.1 The goal
of sedation for surgery under regional anaesthesia is to
enhance patient comfort, to preserve protective airway
reflexes, to avoid sympathetic stimulation and to help
maintain haemodynamic stability during the surgical
procedure.2 Many single and multiple drug regimes have
been used for this purpose with varying degrees of success.3,4
Midazolam, propofol and opioids like fentanyl or
remifentanil are often used, either alone or in combination.5-6
While midazolam can be used as the sole supplement
to regional anaesthesia, it can prove difficult to titrate and
can lead to either undesirably deep sedation or a confused
and   uncooperative patient.2 Therefore other drugs, usually
opioids, are often used in combination with midazolam or
other sedatives for this purpose so as to prevent undesirable
effects of both agents, as a smaller dose of each drug will be
required to maintain adequate sedation. Midazolam and
fentanyl combination is a popular regime used to enhance
patient comfort during regional and local anaesthesia.2,6 In
Pakistan fentanyl is often unavailable and other opioid
agents like pethidine or morphine are combined with
midazolam to provide sedation during regional anaesthesia.
However, these combinations of midazolam and opioids can
cause significant intraoperative respiratory depression.3
Tramadol hydrochloride is a synthetic atypical
opioid with central-acting analgesic properties. When
compared with other opioids, it does not induce significant
respiratory depression or histamine release.3 The objective
of our clinical trial was to study the cardio-respiratory
stability, the acceptability to the patient and surgeon, and the
incidence of intra-operative and immediate postoperative
complications with midazolam-pethidine combination
(group P) and midazolam-tramadol combination (group T)
in a cohort of patients undergoing regional anaesthesia.
Patients and Methods
Forty American Society of Anaesthesiologists
(ASA) 1-111 patients, both female and male, between 40-65
years of age undergoing either inguinal hernia repair or
transurethral resection of the prostate (TURP) under sub-
arachnoid block (spinal anaesthesia) were included in the
study. The patients were randomly divided into two groups
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Objective: Intraoperative comfort and patient satisfaction during surgical procedures under regional anaesthesia
can be improved with the use of supplemental intravenous sedation. The authors conducted a study to compare
two sedation techniques for surgical procedures performed under regional anaesthesia, i.e., midazolam and
pethidine combination compared with midazolam and tramadol combination. 
Methods: Forty adult American Society of Anaesthesiologists (ASA) grade 1-111 patients, aged between 40-65
years undergoing surgery under regional anaesthesia (sub-arachnoid block) were included. The patients were
randomly divided into two groups. All patients received standardized premedication, intraoperative monitoring
and oxygen therapy. Group A patients received midazolam 0.03 mg/kg followed by pethidine 20 mg
intravenously, and group B patients received midazolam 0.03 mg/kg followed by tramadol 20 mg intravenously
after the institution of regional anaesthesia. Monitoring included ECG, blood pressure, respiratory rate, oxygen
saturation and sedation score. Complications, if any, were recorded. Monitoring was continued during the
recovery room stay. All patients were interviewed in the evening and time of ambulation and rating of OR
experience was noted. 
Results: Data analysis showed no significant difference between pethidine and tramadol for all the
haemodynamic variables (p = >0.05). There was also no significant difference in patient's and surgeon's
assessment of their experience. Complications and recovery characteristics also did not show any significant
difference. 
Conclusion: Midazolam-tramadol combination may be used as an alternative to midazolam-pethidine
combination for sedation during surgical procedures performed under regional anaesthesia (JPMA 57:548:2007).
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P and T using the opaque sealed envelope method. A total of
20 patients in each group (P and T) were required in order
to have a power of 80 percent, level of significance of 5
percent and a change in haemodynamic measures from
baseline to the endpoint of 20 percent. Patients with history
of renal or hepatic dysfunction, convulsive disorders, and
allergy to study drugs were excluded, as were those who
were unable to follow instructions, or refused to have
surgery under regional anaesthesia or in whom regional
anaesthesia was contraindicated. Approval was taken from
the institutional ethical review committee and written
informed consent was obtained from all patients. 
All patients were premedicated with oral midazolam
7.5mg given one hour prior to surgery. On arrival in the
operating room a dorsal hand vein was cannulated with an
18 gauge cannula and infusion of Ringer's lactate solution
was started. A continuous electrocardiogram (ECG-lead 11),
the finger probe of a pulse oximeter and a non-invasive
blood pressure (BP) monitor set to take readings at five
minute intervals were attached to the patient. Datex
Ohmeda AS/5 monitors were used for all patients. After a
resting period of five minutes a baseline reading of heart
rate, systolic, diastolic and mean blood pressure, oxygen
saturation on room air and respiratory rate was recorded.
Monitoring was continued during the performance of the
regional block and throughout surgery. All patients were
given oxygen 4L/minute via Hudson facemask. 
After performance of a successful spinal block,
sedation was started with midazolam 0.03 mg/kg body
weight intravenous (IV) bolus given over ten seconds. This
was followed two minutes later with pethidine 20 mg IV
bolus (group P) or tramadol 20 mg IV bolus (group T). The
study drugs were administered over 20 seconds. Both
pethidine and tramadol were diluted to a concentration of 10
mg/ml and drawn in a 5 ml syringe which was labeled as
"study drug". Blinding was done by ensuring that the
anaesthetist concerned with giving the drug (Anaesthetist
A) was different from the one observing the patient and
recording the parameters (Anaesthetist B). Anaesthetist A
prepared the study drug.
The criteria for administering additional boluses of
pethidine 10 mg IV in group P patients and tramadol 10 mg
IV in group T patients included an increase in blood
pressure of more than 30% above the control values and
patient's request if he/she experienced pain, discomfort or
anxiety. Intraoperative monitoring included ECG, non-
invasive blood pressures (systolic, diastolic and mean [SAP,
DAP, MAP]), heart rate (HR), respiratory rate (RR) and
peripheral oxygen saturation (SpO2). Level of sedation
throughout the procedure was assessed using the Ramsay
Sedation Score (RSS) (1 = anxious, agitated, restless; 2 =
cooperative, tranquil, oriented; 3 = drowsy but responsive to
verbal commands; 4 = asleep, responsive to light
stimulation, sound; 5 = asleep, slow response to stimulation;
6 = asleep, no response to stimulation). The aim was to keep
the RSS between 2 and 4 throughout the procedure so that
the patient remained responsive to commands. The readings
were charted every ten minutes on a pre-designed study
form. The lowest value of oxygen saturation and the highest
and lowest pulse rate recorded during the procedure were
also charted. Any other problems like snoring, vomiting, or
restlessness were also noted. Administration of any
additional bolus was recorded alongwith the time and the
reason for the administration. At the end of the surgery the
surgeon was asked to assess the operating conditions as
poor, fair or good.
Patients were followed up in the post-anaesthesia
care unit (PACU) and their haemodynamic status and
respiratory rate were monitored every 15 minutes by the
PACU nurses who were blinded to the study group. The
presence of complications like nausea or vomiting,
hypertension or hypotension, bradycardia or tachycardia
was also noted. The patient was visited in the ward on the
same evening, four hours after discharge from the PACU, by
one of the researchers and asked about any nausea or
vomiting after discharge from the recovery room. Patient's
assessment of his operating room experience and his
willingness to have the same anaesthetic technique again, if
required, was also asked.
The data was entered and verified using the
statistical software SPSS version 13.0. Means and standard
deviations were computed for group P and T separately for
continuous variables and comparison of means at the
baseline for the two groups were made using independent
samples student's t-test. Mann-Whitney test was used to
compare intra-operative sedation score at baseline for the
two groups. Repeated Measures ANOVA was used to
compare systolic blood pressure, diastolic blood pressure,
mean blood pressure, heart rate and oxygen saturation at
different time points between the two groups. Chi-square
test was used for categorical data. Repeated Measures
ANOVA for ordinal measures was used to compare sedation
scores at different time points between the two groups. A p-
value of less than 0.05 was taken as statistically significant.
Results
The two groups were comparable demographically
[Table 1]. There were no statistically significant differences
between the two groups with regards to the systolic blood
pressure (group P 120 versus group T 130; P-value = 0.18),
diastolic blood pressure (group P 75 versus group T 77; P-
value = 0.5) and the mean blood pressure (group P 90 versus
group T 97; P-value = 0.5) [figure 1] at any point in time.
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The mean heart rate was also not statistically different
between the groups [Figure 1] (group P 71 versus group T
67; P-value = 0.43), however, a decline in HR and arterial
pressure was observed with time in each group [Figure 1],
although all readings were within 20% of baseline. The
maximum decline was observed in group P, i.e. 13 percent
from the baseline in a time period of 50 minutes, while it
was under 12 percent in group T. None of the patients in
either group displayed any episode of significant
tachycardia or bradycardia, the heart rate remaining within
20% of baseline at all times. 
There was no statistically significant difference in
the intraoperative peripheral oxygen saturation (SpO2)
within the groups or between the two groups at any point in
time (group P 98 [SD 1.2] versus group T 99 [SD 1.16]; P-
value = 0.88). The SpO2 did not drop below 95% in any
patient at any time. There was also no statistically
significant difference in the respiratory rate within the
groups or between the two groups at any point in time
(group P 17 [SD 3.7] versus group T 17 [SD 3.4]; P-value =
1). There was no incidence of airway compromise or fall in
respiratory rate to below 10/minute in any patient. 
Ten minutes after administration of the study drugs,
19 patients in group P and 18 patients in group T showed the
desired levels of sedation, i.e., sedation score of 2, 3 or 4.
One patient in group P was oversedated having a score of 6
and one patient in group T had a sedation score of 5 at 10
minutes, whereas one patient in group T had a score of 1
showing inadequate sedation. At 30 minutes three patients
in group P had a sedation score of 6 and three in group T had
a score of 5, whereas all the other patients in both groups
had achieved desired levels of sedation, whereas at 60
minutes only one patient in each group showed sedation
score of 5 [Table 2]. Surgical procedure finished within 60
minutes in seven patients in group P and four patients in
group T. In the remaining patients, surgery finished within
the next 30 minutes. No significant difference was observed
in the sedation scores between the two groups at any point
of assessment (p=0.1035), although a significant difference
was observed in the sedation scores within the group with
time, the score increasing with time. This difference was
most significant between time 0 minute and time 50 minutes
(p=<0.0001).
Two patients in group P needed additional boluses.
One patient developed shivering during TURP and was
given 10 mg bolus of pethidine twice, after which the
shivering settled. The second patient in group P was given a
bolus because he became restless towards the end of left
inguinal herniorrhaphy as the procedure became prolonged.
Only one patient in group T required an additional bolus as
he was feeling some discomfort near the end of the
Table 1. Patient Characteristics: (Mean, Standard deviation or
absolute numbers); P = Pethidine, T = Tramadol. 
Demographic Data Group P (n=20) Group T (n=20)
Age (Yr)
Weight (Kg)
Gender (Male / Female)
ASA I/II/III (n)
TURP/Inguinal hernia repair
54 (29 - 65)
70.3 (10.4)
11/9
5/11/4
8/12
58 (33-65)
69.2 (11.7)
10/10
6/9/5
8/12
Table 2. Intra-operative Sedation Scores.
Time Group P Group T
m Sedation Score n Sedation Score
1 2 3 4 5 6 1 2 3 4 5 6
10 mins
20 mins
30 mins
40 mins
50 mins
60 mins
20
20
20
20
17
13
0
0
0
0
0
0
5
5
7
7
5
4
11
7
5
4
5
5
3
5
5
6
5
3
0
0
0
0
1
1
1
3
3
3
1
0
20
20
20
20
19
16
1
1
0
0
0
0
5
4
4
4
8
5
7
7
9
11
7
6
6
4
4
3
2
4
1
4
3
1
2
1
0
0
0
1
0
0
Figure 1. Intraoperative mean arterial pressure and heart rate in the two groups at different time
points. P = patients given Pethidine     T = patients given Tramadol
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procedure. There was no incidence of intraoperative
complications (tachycardia, bradycardia, hypoxia,
vomiting, snoring etc) in either group.
Similar to the intraoperative parameters, no
statistically significant difference was found between the
two groups in the PACU with regards to the blood pressure
(MAP: group P 92.5 [SD 13.4] versus group T 97.8 [SD 17];
P-value = 0.25), heart rate (group P 72 [SD of 21] versus
group T 67 [SD 15]; P-value = 0.46), respiratory rate (group
P 19 [SD 3] versus group T 19 [SD 2]; P-value = 0.52) and
the SpO2 (group P 98.95 [SD 1] versus group T 98.49 [SD
1.5]; P-value = 0.33). One patient in group P and two in
group T had nausea and vomiting in the PACU which
responded to intravenous metoclopramide. There was no
incidence of complications like hypertension, hypotension,
tachycardia or bradycardia in any patient during their stay in
the recovery room. There was no statistically significant
difference in the length of PACU stay with the two
techniques with all patients discharged within two hours in
both groups.
All patients except one in each group were willing to
have the same anaesthesia technique in any subsequent
procedure, although the two patients who refused reported
satisfaction with their operating room stay and did not
report of any complaints during the procedure. All the
surgeons expressed satisfaction with the technique.  
Discussion
Our study shows that both midazolam-pethidine
combination or midazolam-tramadol combination, when
used for intraoperative sedation during regional anaesthesia,
are satisfactory in terms of cardio-respiratory stability,
acceptable sedation, acceptability to the patient and
surgeon, and the incidence of intraoperative and immediate
postoperative complications. 
The aim of sedation during regional anaesthesia is to
permit the patient to tolerate the procedure with minimal
anxiety and discomfort.7-10 Ideally during sedation, the
patient should be relaxed, comfortable and cooperative
throughout the procedure.2,11 An ideal sedation technique
should produce a rapid and smooth onset of action with
minimal cardiorespiratory depression and fast recovery.2
Benzodiazepines tend to have prolonged duration of action
and even midazolam when used as a sole agent, may cause
prolonged memory impairment and delayed recovery.12
Propofol has ideal pharmacokinetic properties for this
purpose, but its cost is still a limiting factor in a developing
country like ours. In our hospital, it is a common practice to
use midazolam alongwith pethidine or fentanyl, when
available, for sedation during regional anaesthesia. The
addition of opioids to the sedation regimen allows for a
smaller dose of midazolam to achieve the desired effect,
thus avoiding delay in recovery besides adding an element
of analgesia to the sedation, but can lead to an increase in
the incidence of respiratory depression and other side
effects like nausea and vomiting.10,13
Tramadol hydrochloride has been shown to be safe
and reliable with a low incidence of side effects when used
as an adjuvant to regional anaesthesia for sedation and
analgesia without loss of cooperation in patients of all
ages.14 An outstanding aspect of tramadol is its extremely
low ability to produce clinically relevant respiratory
depression, which is claimed to be negligible in comparison
with other opioids.13-16 The most common adverse effects of
tramadol include dizziness, incoordination, nausea,
vomiting and dry mouth16, but the dose required for
sedation in combination with midazolam is low enough to
prevent most of these side effects.    
The results of this study have shown that both
midazolam-pethidine combination and midazolam-tramadol
combination produce satisfactory sedation in patients
undergoing surgical procedures under regional anaesthesia.
The two groups did not show any significant
cardiorespiratory depression, and all patients in both groups
remained haemodynamically stable throughout their
surgical procedures. Patients in group T demonstrated a
slight rise in systolic, diastolic and mean arterial pressures
soon after administration of tramadol, which settled down
within 10-15 minutes. This rise was not clinically
significant. Such haemodynamic effects have earlier been
recorded after intravenous administration of tramadol17,
where during anaesthesia systolic arterial pressures were
found to rise 14-16 mm Hg and diastolic pressures 10-12
mm Hg after I.V injection of tramadol for 4-6 minutes,
returning to baseline within 15 minutes.
All other parameters including heart rate, respiratory
rate and oxygen saturation remained stable in both groups,
which is consistent with other authors' reports on
tramadol.3,13,16,17 In general, the heart rate showed a lower
value in group T patients compared to those in group P, both
during surgery (Figure 1) and in the PACU (Table 1), but
this difference was not statistically significant. The
frequency of side effects (tachycardia, bradycardia,
hypoxia, vomiting, snoring etc) was low in both groups,
both during the operation and in the recovery period. Only
three patients, two in group P and one in group T, required
additional boluses. One patient in group P developed
shivering during TURP and was given 10 mg bolus of
pethidine twice, after which the shivering settled. Both
pethidine and tramadol are known for their efficacy in the
treatment of postoperative shivering and shivering during
spinal anaesthesia18, therefore the available study drug
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(pethidine in this case) was utilized to manage this problem
intraoperatively. The two other patients who received one
additional bolus each, both required it towards the ends of
their procedures, when they felt discomfort and were getting
restless. As in most of the other patients included in the
study, surgical procedures were of shorter duration, this
problem was not seen in them. Further studies designed to
include patients undergoing procedures of longer duration
(two hours or more) need to be undertaken to determine the
time when most patients receiving these drug combinations
would require a repeat bolus.
All the surgeons showed satisfaction with the
operating conditions in all patients in both groups. As
tramadol, unlike pethidine, is not a controlled drug in
Pakistan, its ease of availability is an added advantage to its
use for the purpose of sedation during regional anaesthesia.
Thus, our results suggest that midazolam-tramadol
combination can be used as an alternative to midazolam-
pethidine combination as an adjunct to regional anaesthesia.
The authors believe that this combination would be of
particular advantage in elderly patients who are at an
increased risk of respiratory depression with opioid agents,
but further research needs to be done, using this
combination in elderly and high risk patients, before any
recommendations could be made.   
Conclusion
Both techniques appeared satisfactory in terms of
physiological stability, acceptable sedation, and patient and
surgeon acceptability. Thus our results suggest that
midazolam-tramadol combination may be used as an
alternative to midazolam-pethidine combination for
sedation during surgical procedures performed under
regional anaesthesia.
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